Sedana Medical AB (7D2A) Stock Statistics & Valuation Metrics
Total Valuation
Sedana Medical AB has a market cap or net worth of EUR 86.09M. The enterprise value is EUR 937.07M.
- Market Cap
- EUR 86.09M
- Enterprise Value
- EUR 937.07M
Share Statistics
Sedana Medical AB has 99,336,960 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 99,336,960
- Owned by Insiders
- ―
- Owned by Institutions
- 0.23%
Financial Efficiency
Sedana Medical AB’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is -3.55%.
- Return on Equity (ROE)
- -0.07
- Return on Assets (ROA)
- -0.06
- Return on Invested Capital (ROIC)
- -3.55%
- Return on Capital Employed (ROCE)
- -0.04
- Revenue Per Employee
- 1.71M
- Profits Per Employee
- -506.36K
- Employee Count
- 117
- Asset Turnover
- 0.21
- Inventory Turnover
- 1.52
Valuation Ratios
The current PE Ratio of Sedana Medical AB is -27.75. Sedana Medical AB’s PEG ratio is 1.25.
- PE Ratio
- -27.75
- PS Ratio
- 4.83
- PB Ratio
- 1.09
- Price to FCF
- -15.82
- Price to Operating Cash Flow
- -72.52
- PEG Ratio
- 1.25
Income Statement
In the last 12 months, Sedana Medical AB had revenue of 200.23M and earned -59.24M in profits. Earnings per share was -0.60.
- Revenue
- 200.23M
- Gross Profit
- 142.71M
- Operating Income
- -32.16M
- Pretax Income
- -57.26M
- Net Income
- -59.24M
- EBITDA
- -10.12M
- Earnings Per Share (EPS)
- -0.60
Cash Flow
In the last 12 months, operating cash flow was -13.20M and capital expenditures -47.31M, giving a free cash flow of -60.52M billion.
- Operating Cash Flow
- -13.20M
- Free Cash Flow
- -60.52M
- Free Cash Flow per Share
- -0.61
Dividends & Yields
Sedana Medical AB pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -6.32%
- Earnings Yield
- -3.61%
Stock Price Statistics
- Beta
- 1.38
- 52-Week Price Change
- -4.13%
- 50-Day Moving Average
- 0.85
- 200-Day Moving Average
- 0.83
- Relative Strength Index (RSI)
- 46.84
- Average Volume (3m)
- ―
Important Dates
Sedana Medical AB upcoming earnings date is Feb 11, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Oct 22, 2026
- Next Earnings Date
- Feb 11, 2027
- Ex-Dividend Date
- ―
Financial Position
Sedana Medical AB as a current ratio of 3.40, with Debt / Equity ratio of 0.52%
- Current Ratio
- 3.40
- Quick Ratio
- 2.66
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 8.53
- Interest Coverage Ratio
- -22.12
Taxes
In the past 12 months, Sedana Medical AB has paid 1.98M in taxes.
- Income Tax
- 1.98M
- Effective Tax Rate
- -0.03
Enterprise Valuation
Sedana Medical AB EV to EBITDA ratio is -171.43, with an EV/FCF ratio of -15.27.
- EV to Sales
- 4.66
- EV to EBITDA
- -171.43
- EV to Free Cash Flow
- -15.27
- EV to Operating Cash Flow
- -69.99
Balance Sheet
Sedana Medical AB has EUR 39.72M in cash and marketable securities with EUR 6.27M in debt, giving a net cash position of EUR 33.46M billion.
- Cash & Marketable Securities
- EUR 39.72M
- Total Debt
- EUR 6.27M
- Net Cash
- EUR 33.46M
- Net Cash Per Share
- EUR 0.34
- Tangible Book Value Per Share
- EUR 0.79
Margins
Gross margin is 71.57%, with operating margin of -17.12%, and net profit margin of -17.40%.
- Gross Margin
- 71.57%
- Operating Margin
- -17.12%
- Pretax Margin
- -16.14%
- Net Profit Margin
- -17.40%
- EBITDA Margin
- -2.72%
- EBIT Margin
- -17.12%
Analyst Forecast
The average price target for Sedana Medical AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 3.23%
- EPS Growth Forecast
- 14.32%
